Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (atsiveria naujas langas)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Šaltinis‎: J Bone Joint Surg Am 2013;95(21):1969-74.

Kodas‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (atsiveria naujas langas)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (atsiveria naujas langas)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Šaltinis‎: J Bone Joint Surg Am 2013;95(21):1961-8.

Kodas‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (atsiveria naujas langas)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (atsiveria naujas langas)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Šaltinis‎: Ann Surg 2019;269(5):794-804.

Kodas‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (atsiveria naujas langas)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (atsiveria naujas langas)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Šaltinis‎: Spine 2009;34(19):2096-103.

Kodas‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (atsiveria naujas langas)

The combined use of oral and topical tranexamic acid is a safe, efficient and low-cost method in reducing blood loss and transfusion rates in total knee arthroplasty. (atsiveria naujas langas)

Cankaya D, Dasar U, Satilmis AB, Basaran SH, Akkaya M, Bozkurt M.

Šaltinis‎: J Orthop Surg 2017;25(1):2309499016684725.

Kodas‎: PubMed 28176599

DOI‎: 10.1177/2309499016684725

https://www.ncbi.nlm.nih.gov/pubmed/28176599 (atsiveria naujas langas)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (atsiveria naujas langas)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Šaltinis‎: J Arthroplasty 2013;28(8 Suppl):74-7.

Kodas‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (atsiveria naujas langas)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (atsiveria naujas langas)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Šaltinis‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Kodas‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (atsiveria naujas langas)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (atsiveria naujas langas)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Šaltinis‎: J Knee Surg 2017;30(5):460-6.

Kodas‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (atsiveria naujas langas)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (atsiveria naujas langas)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Šaltinis‎: J Arthroplasty 2017;32(8):2375-80.

Kodas‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (atsiveria naujas langas)

Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. (atsiveria naujas langas)

DiBlasi JF, Smith RP, Garavaglia J, Quedado J, Frye BM, Dietz MJ.

Šaltinis‎: Am J Orthop 2016;45(7):E439-43.

Kodas‎: PubMed 28005108

https://www.ncbi.nlm.nih.gov/pubmed/28005108 (atsiveria naujas langas)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (atsiveria naujas langas)

Dobosz B, Dutka J, Dutka L, Maleta P.

Šaltinis‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

Kodas‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (atsiveria naujas langas)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (atsiveria naujas langas)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Šaltinis‎: Spine J 2017;17(7):977-82.

Kodas‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (atsiveria naujas langas)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (atsiveria naujas langas)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Šaltinis‎: Orthop Clin North Am 2017;48(2):109-15.

Kodas‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (atsiveria naujas langas)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (atsiveria naujas langas)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Šaltinis‎: Ir Med J 2018;111(4):730.

Kodas‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (atsiveria naujas langas)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (atsiveria naujas langas)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Šaltinis‎: Anesth Analg 2022;135(3):576-85.

Kodas‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (atsiveria naujas langas)

Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study. (atsiveria naujas langas)

Frank SM, Wasey JO, Dwyer IM, Gokaslan ZL, Ness PM, Kebaish KM.

Šaltinis‎: J Orthop Surg Res 2014;9:50.

Kodas‎: PubMed 24997589

DOI‎: 10.1186/s13018-014-0050-2

https://www.ncbi.nlm.nih.gov/pubmed/24997589 (atsiveria naujas langas)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (atsiveria naujas langas)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Šaltinis‎: J Shoulder Elbow Surg 2016;25(4):614-8.

Kodas‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (atsiveria naujas langas)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (atsiveria naujas langas)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Šaltinis‎: Transfusion 2017;57(2):357-66.

Kodas‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (atsiveria naujas langas)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (atsiveria naujas langas)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Šaltinis‎: J Arthroplasty 2013;28(8 Suppl):137-9.

Kodas‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (atsiveria naujas langas)

Cell saver for adult spinal deformity surgery reduces cost. (atsiveria naujas langas)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Šaltinis‎: Spine Deform 2017;5(4):272-6.

Kodas‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (atsiveria naujas langas)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (atsiveria naujas langas)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Šaltinis‎: J Am Acad Orthop Surg 2021;29(22):961-9.

Kodas‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (atsiveria naujas langas)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (atsiveria naujas langas)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Šaltinis‎: Orthopedics 2017;40(6):e1044-9.

Kodas‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (atsiveria naujas langas)

Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. (atsiveria naujas langas)

Harris RN, Moskal JT, Capps SG.

Šaltinis‎: J Arthroplasty 2015;30(2):192-5.

Kodas‎: PubMed 25534861

DOI‎: 10.1016/j.arth.2014.08.020

https://www.ncbi.nlm.nih.gov/pubmed/25534861 (atsiveria naujas langas)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (atsiveria naujas langas)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Šaltinis‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

Kodas‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (atsiveria naujas langas)

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial. (atsiveria naujas langas)

Karayiannis PN, Agus A, Bryce L, Hill JC, Beverland D.

Šaltinis‎: Bone Jt Open 2022;3(7):536-42.

Kodas‎: PubMed 35816170

DOI‎: 10.1302/2633-1462.37.BJO-2021-0213.R1

https://www.ncbi.nlm.nih.gov/pubmed/35816170 (atsiveria naujas langas)

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. (atsiveria naujas langas)

Kotzé A, Carter LA, Scally AJ.

Šaltinis‎: Br J Anaesth 2012;108(6):943-52.

Kodas‎: PubMed 22593128

DOI‎: 10.1093/bja/aes135

https://www.ncbi.nlm.nih.gov/pubmed/22593128 (atsiveria naujas langas)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (atsiveria naujas langas)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Šaltinis‎: Transfusion 2017;57(6):1347-58.

Kodas‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (atsiveria naujas langas)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (atsiveria naujas langas)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Šaltinis‎: Br J Anaesth 2007;99(6):794-800.

Kodas‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (atsiveria naujas langas)

A safe, simple and cost-effective protocol for blood transfusion in primary total knee replacement. (atsiveria naujas langas)

Mehra A, Murray J, DeAlwis C.

Šaltinis‎: Ann R Coll Surg Engl 2004;86(4):260-2.

Kodas‎: PubMed 15239867

DOI‎: 10.1308/147870804551

https://www.ncbi.nlm.nih.gov/pubmed/15239867 (atsiveria naujas langas)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (atsiveria naujas langas)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Šaltinis‎: J Arthroplasty 2018;33(6):1705-12.

Kodas‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (atsiveria naujas langas)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (atsiveria naujas langas)

Moskal JT, Harris RN, Capps SG.

Šaltinis‎: J Arthroplasty 2015;30(3):365-8.

Kodas‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (atsiveria naujas langas)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (atsiveria naujas langas)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Šaltinis‎: Blood Transfus 2013;11(2):260-71.

Kodas‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (atsiveria naujas langas)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (atsiveria naujas langas)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Šaltinis‎: Blood Transfus 2014;12(1):40-9.

Kodas‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (atsiveria naujas langas)

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. (atsiveria naujas langas)

Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH.

Šaltinis‎: Transfusion 2011;51(1):118-24.

Kodas‎: PubMed 20624257

DOI‎: 10.1111/j.1537-2995.2010.02783.x

https://www.ncbi.nlm.nih.gov/pubmed/20624257 (atsiveria naujas langas)

Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. (atsiveria naujas langas)

Nichols CI, Vose JG.

Šaltinis‎: J Arthroplasty 2016;31(3):583-589.e1.

Kodas‎: PubMed 26699673

DOI‎: 10.1016/j.arth.2015.10.013

https://www.ncbi.nlm.nih.gov/pubmed/26699673 (atsiveria naujas langas)

The efficacy, safety, and cost-effectives of combined administration of intravenous and local tranexamic acid in the management of patients undergoing primary total hip arthroplasty: a prospective, blinded and randomized clinical study. (atsiveria naujas langas)

Örs Ç, Çaylak R.

Šaltinis‎: Acta Orthop Traumatol Turc 2021;55(5):422-7.

Kodas‎: PubMed 34730529

DOI‎: 10.5152/j.aott.2021.20397

https://www.ncbi.nlm.nih.gov/pubmed/34730529 (atsiveria naujas langas)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (atsiveria naujas langas)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Šaltinis‎: Open Orthop J 2011;5:44-8.

Kodas‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (atsiveria naujas langas)

ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. (atsiveria naujas langas)

Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J.

Šaltinis‎: Anesth Analg 2022;135(3):448-58.

Kodas‎: PubMed 35977355

DOI‎: 10.1213/ANE.0000000000006065

https://www.ncbi.nlm.nih.gov/pubmed/35977355 (atsiveria naujas langas)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (atsiveria naujas langas)

Phan DL, Ani F, Schwarzkopf R.

Šaltinis‎: J Arthroplasty 2016;31(3):579-82.

Kodas‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (atsiveria naujas langas)

Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. (atsiveria naujas langas)

Pitta M, Zawadsky M, Verstraete R, Rubinstein A.

Šaltinis‎: Transfusion 2016;56(2):466-71.

Kodas‎: PubMed 26509250

DOI‎: 10.1111/trf.13354

https://www.ncbi.nlm.nih.gov/pubmed/26509250 (atsiveria naujas langas)

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. (atsiveria naujas langas)

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

Šaltinis‎: BMJ 2014;349:g4829.

Kodas‎: PubMed 25116268

DOI‎: 10.1136/bmj.g4829

https://www.ncbi.nlm.nih.gov/pubmed/25116268 (atsiveria naujas langas)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (atsiveria naujas langas)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Šaltinis‎: Clin Orthop Relat Res 2010;468(7):1905-11.

Kodas‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (atsiveria naujas langas)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (atsiveria naujas langas)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Šaltinis‎: J Arthroplasty 2018;33(7):2092-9.e9.

Kodas‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (atsiveria naujas langas)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (atsiveria naujas langas)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Šaltinis‎: Transfus Med 2009;19(4):202-6.

Kodas‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (atsiveria naujas langas)

Improved patient blood management and cost saving in hip replacement surgery through the implementation of pre-operative Sucrosomial® iron supplementation: a quality improvement assessment study. (atsiveria naujas langas)

Scardino M, Di Matteo B, Martorelli F, Tanzi D, Kon E, D'Amato T.

Šaltinis‎: Int Orthop 2019;43(1):39-46.

Kodas‎: PubMed 30232527

DOI‎: 10.1007/s00264-018-4149-7

https://www.ncbi.nlm.nih.gov/pubmed/30232527 (atsiveria naujas langas)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (atsiveria naujas langas)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Šaltinis‎: Int Orthop 2019;43(12):2707-14.

Kodas‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (atsiveria naujas langas)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (atsiveria naujas langas)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Šaltinis‎: J Orthop Surg Res 2011;6:22.

Kodas‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (atsiveria naujas langas)

Increased hospital costs associated with red blood cell transfusion. (atsiveria naujas langas)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Šaltinis‎: Transfusion 2015;55(5):1082-9.

Kodas‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (atsiveria naujas langas)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (atsiveria naujas langas)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Šaltinis‎: J Arthroplasty 2014;29(8):1512-5.

Kodas‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (atsiveria naujas langas)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (atsiveria naujas langas)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Šaltinis‎: J Arthroplasty 2020;35(11):3084-8.

Kodas‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (atsiveria naujas langas)

Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: a randomized clinical trial. (atsiveria naujas langas)

Wu Y, Zeng Y, Hu Q, Li M, Bao X, Zhong J, Shen B.

Šaltinis‎: Thromb Res 2018;171:143-8.

Kodas‎: PubMed 30312799

DOI‎: 10.1016/j.thromres.2018.10.006

https://www.ncbi.nlm.nih.gov/pubmed/30312799 (atsiveria naujas langas)

Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. (atsiveria naujas langas)

Ye X, Lafuma A, Torreton E, Arnaud A.

Šaltinis‎: BMC Health Serv Res 2013;13:186.

Kodas‎: PubMed 23692862

DOI‎: 10.1186/1472-6963-13-186

https://www.ncbi.nlm.nih.gov/pubmed/23692862 (atsiveria naujas langas)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (atsiveria naujas langas)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Šaltinis‎: Int Orthop 2007;31(3):303-8.

Kodas‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (atsiveria naujas langas)

Efficacy and safety of tranexamic acid in total hip replacement: a PRISMA-compliant meta-analysis of 25 randomized controlled trials. (atsiveria naujas langas)

Zhu J, Zhu Y, Lei P, Zeng M, Su W, Hu Y.

Šaltinis‎: Medicine 2017;96(52):e9552.

Kodas‎: PubMed 29384974

DOI‎: 10.1097/MD.0000000000009552

https://www.ncbi.nlm.nih.gov/pubmed/29384974 (atsiveria naujas langas)